2990 Lu, Bo - Thomas Jefferson University - Thomas Jefferson University
bxl017

Bo Lu, MD

Contact Dr. Lu

G-301 Bodine Cancer Center
111 S. 11th Street
Philadelphia, PA 19107

(215) 955-6705
(215) 503-0013 fax

Most Recent Peer-reviewed Publications

  1. IL-11 attenuates liver ischemia/reperfusion injury (IRI) through STAT3 signaling pathway in mice
  2. A method of detecting sea fogs using CALIOP data and its application to improve MODIS-based sea fog detection
  3. Tunable Magnetic Reversal of Rare-Earth Chromites Yb1−xCa xCrO3
  4. A method of surface marker location optimization for tumor motion estimation in lung stereotactic body radiation therapy
  5. Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests
  6. Wind tunnel technique for transonic full-model flutter test
  7. Gel mesh as "brake" to slow down DNA translocation through solid-state nanopores
  8. Serum clusterin as a tumor marker and prognostic factor for patients with esophageal cancer
  9. Ghost marker detection and elimination in marker-based optical tracking systems for real-time tracking in stereotactic body radiotherapy
  10. A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect
  11. Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer
  12. Prevention of gross setup errors in radiotherapy with an efficient automatic patient safety system
  13. Prevention of gross setup errors in radiotherapy with an efficient automatic patient safety system.
  14. A further investigation of the centroid-to-centroid method for stereotactic lung radiotherapy: A phantom study
  15. Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab
  16. PM02734 (Elisidepsin) induces caspase-independent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of death-associated protein kinase (Clinical Cancer Research (2011))
  17. A study of IMRT planning parameters on planning efficiency, delivery efficiency, and plan quality
  18. Opportunities and challenges in the era of molecularly targeted agents and radiation therapy
  19. ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinoma
  20. ALK inhibitor PF02341066 (Crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALK
0